Exane Derivatives’s Immunomedics Inc IMMU Stock Holding History

Exane Derivatives’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-138	Closed	-$11.7K	–	884
2020 Q3	$11.7K	Hold	138	–	–	﹤0.01%	460
2020 Q2	$4.89K	Hold	138	–	–	﹤0.01%	453
2020 Q1	$1.86K	Hold	138	–	–	﹤0.01%	504
2019 Q4	$2.7K	Hold	138	–	–	﹤0.01%	475
2019 Q3	$1.83K	Hold	138	–	–	﹤0.01%	499
2019 Q2	$1.91K	Sell	138 -5,861	-98%	-$88.2K	﹤0.01%	513
2019 Q1	$115K	Buy	5,999 +3,753	+167%	+$60.5K	0.02%	282
2018 Q4	$32K	Buy	+2,246	New	+$44.6K	0.01%	409

Exane Derivatives's IMMU Position: Q4 2020 in Review

Exane Derivatives sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 138 shares — an estimated $11.7K sold.

Exane Derivatives first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $115K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Exane Derivatives reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 138 Immunomedics Inc shares in Q4 2020, an estimated $11.7K.
Exane Derivatives first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
Exane Derivatives's Immunomedics Inc position peaked at $115K in Q1 2019.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.